Somatic T cell hybridomas can be used to monitor hybrid stimulation in chromogenic lacZ assays. A the processing and presentation of T cell antigens in comparison of the sensitivity of the LCMV-specific the MHC class I pathway. Here we report the hybridomas in the lacZ assay with the performance generation of hybridomas by fusion of three cytotoxof the parental CTL lines in chromium release assays 2 4 ic T lymphocyte (CTL) lines specific for different revealed a 10 to 10 -fold lower sensitivity of the epitopes of the lymphocytic choriomeningitis virus hybridoma-based lacZ assay. Accordingly, the recog-(LCMV) glycoprotein and nucleoprotein. The cell nition of the LCMV-glycoprotein epitope GP33 by a line BWZ.36.1 / CD8a used as a fusion partner is a T GP33-specific hybridoma was reduced by the proteacell receptor-deficient lymphoma line some specific inhibitor lactacystin to a greater extent 2 2 (BW5147a b ) expressing CD8a and a lacZ reportand at a lower concentration than CTL recognition in er construct under the control of the IL-2 promotor / a chromium release assay. Hence, the hybridomaenhancer. This system permits monitoring of T cell based lacZ assay is complementary to the chromium release assay in that it covers a lower range of sensitivity which allows the detection of subtle by the H-2D class I molecule: the glycoprotein cules in flow cytometric analysis were selected for (GP) derived peptide epitopes GP33 further characterization. The specificity of the hy-(KAVYNFATC) and GP276 (SGVENPGGYCL) as bridomas both for the respective restriction element well as the nucleoprotein (NP)-derived epitope and for the appropriate epitope was determined in NP396 (FQPQNGQFI) (Gallimore et al., 1998a) . For lacZ assays using LCMV infected or peptide loaded
the H-2L restriction element the immunodominant fibroblast lines of H-2 (MC57) and H-2 (B8) epitope NP118 (RPQASGVYM) has been dehaplotypes as targets. In addition a quantitative lineated. The intracellular processing of these four analysis comparing the detection limits between epitopes appears to be dependent on the proteasome CTLs and hybridomas was performed (Fig. 1A) . al., 1998b). To date, antigen presentation in this trations between 10 and 10 M were used as system has been analyzed by conventional cytolytic targets for hybridomas and CTLs of the respective chromium release assays which are extremely sensispecificity. The CTL-mediated lysis of target cells by periodic restimulation. The laborious maintenance omas needed 10 -10 times higher peptide conof oligoclonal CTL lines, their variability in culture, centrations to show activation in the lacZ assay.
27
and the enormous sensitivity of chromium release Measuring activation of hybridomas started at 10 -28 assays are not ideal prerequisites for monitoring the 10 M concentrations of peptide and increased with efficiency of antigen processing by the proteasome higher concentrations without reaching a maximum 25 because differences in epitope generation (due for even above 10 M peptide. All of the LCMVinstance to interferon-g inducible exchanges of specific hybridomas tested in this study were 100 to proteasome subunits and regulators) may be in the 10,000-fold less sensitive when compared to parental micro-to nano-rather than in the nano-to picomolar CTL lines, which is significantly greater than the range of detection.
10-fold drop in sensitivity previously found for an d We therefore generated somatic T cell hybridomas ovalbumin / H-2K -specific hybridoma (Shastri and b specific for the H-2D restricted epitopes GP33 and Gonzalez, 1993). d GP276 as well as the H-2L restricted epitope As the effector to target (E:T) ratio is used in NP118. Oligoclonal CTL lines were obtained from cytolytic assays to titrate the lytic effect we similarly LCMV infected C57BL / 6 and BALB / c mice by titrated the E:T ratio with our LCMV-specific T cell weekly restimulation as described (Gallimore et al., hybridomas. The result shown for the GP33-specific 1998b) and after the third restimulation the cells CTL line and corresponding hybridoma in Fig. 1B were fused with BWZ.36.1 / CD8a cells as detailed indicates that the lacZ assay likewise responds to the elsewhere (Sanderson and Shastri, 1994) . This fusion E:T ratio. In contrast to the cytolytic assay which partner expresses transfected cDNAs for CD8a and reaches a plateau at an E:T ratio of 10 the colour the bacterial b-galactosidase (lacZ) reporter gene reaction of the lacZ assay displays a steady increase under the transcriptional control of the IL-2 promotor of absorbance for E:T values ranging from 2 to 30. and the nuclear factor of activated T cells (NFAT)-
The lower range of sensitivity in the hybridomaelement of the human IL-2 enhancer. Antigenic based lacZ assay would suggest that deficiencies in stimulation of the generated LCMV-specific T cell the proteasome-dependent generation of T cell epihybridomas can thus be easily monitored in topes should become apparent in the lacZ assay chromogenic lacZ assays as described (Sanderson earlier than in the chromium release assay. In order and Shastri, 1994) .
to test this hypothesis we treated MC57 fibroblasts Three hybridoma clones derived from CTLs spewith different concentrations of the proteasome-speb b cific for GP33 / H-2D , GP276 / H-2D , or NP118 / Hcific inhibitor lactacystin prior to infection with a Peptide titration for GP33 and NP118-specific hybridomas and CTLs: RMA-S (H-2 ) or T2-L cells were pulsed with titrated concentrations of the respective peptides and used as target cells in either a lacZ assay or in a chromium release assay. The left hand axis shows absorbance of enzymatically converted chromogen at 570 nm in lacZ assays, the right hand axis shows the specific chromium release in cytolytic assays. The absorbance obtained by presentation of an irrelevant peptide at a concentration of 0.1 mM is indicated in the upper (GP276) and lower (GP33) panel. (B) Dependence on effector to target (E:T) ratio: MC57 fibroblasts were infected with LCMV-WE at a MOI of 0.01 for 48 h before they were used as targets for lysis by GP33-specific CTLs or as stimulators in a lacZ assay. (C) The effect of titrated amounts of lactacystin on GP33 antigen presentation as monitored in lacZ and chromium release assays. MC57 cells were pretreated with the indicated concentrations of lactacystin for 2 h prior to infection with recombinant vaccinia virus rVVG2 encoding the LCMV glycoprotein (Gallimore et al., 1998b ) at a MOI of 5. After 1.5 h the cells were used as targets in a standard 5 h chromium release assay or a lacZ assay.
recombinant vaccinia virus expressing the LCMV hybridoma was affected to a greater extent and at glycoprotein. The presentation of the GP33 epitope lower concentrations of lactacystin than CTL-mewas then measured both by CTLs in a chromium diated lysis (Fig. 1C) . At a concentration of 1 mM release assay and with our GP33 reactive hybridoma lactacystin, hybridoma activation was consistently in a lacZ assay. Indeed, GP33 recognition by the inhibited by 50-60% whereas the inhibition of specific lysis in chromium release assays ranged
